Literature DB >> 19620037

Kimura's disease presenting with a giant suspensory tumor and associated with membranoproliferative glomerulonephritis.

Rieko Kabashima1, Kenji Kabashima, Shoko Mukumoto, Ryosuke Hino, Yumi Huruno, Naritoshi Kabashima, Yoshiki Tokura.   

Abstract

Kimura's disease is a rare chronic inflammatory disease, which typically occurs in middle-aged Asian men. This benign lymphoproliferative disorder with tissue eosinophilia is clinically characterized by painless subcutaneous swelling or induration, affecting the head and neck region. Here we present a 42-year-old Japanese woman with a giant tumor on the right inguinal region. The tumor was diagnosed as Kimura's disease, because of massive infiltration of lymphoid follicle-forming lymphocytes and eosinophils with elevated serum immunoglobulin E and blood eosinophilia. She also had nephrotic syndrome histopathologically diagnosed as membranoproliferative glomerulonephritis (MPGN). Renal involvement is known as one of the associated conditions with Kimura's disease. The skin and renal diseases were successfully treated with corticosteroids and surgical removal of the mass.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620037     DOI: 10.1684/ejd.2009.0776

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  3 in total

Review 1.  Effective treatment of Kimura's disease with leflunomide in combination with glucocorticoids.

Authors:  Lie Dai; Xiu-Ning Wei; Dong-Hui Zheng; Ying-Qian Mo; Frank Pessler; Bai-Yu Zhang
Journal:  Clin Rheumatol       Date:  2011-02-01       Impact factor: 2.980

2.  A Case of Kimura's Disease as Giant Pedunculated Tumors.

Authors:  Masanao Sakanoue; Shigeto Matsushita; Kazuhiro Kawai; Takuro Kanekura
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

3.  Kimura's disease mimicking thoracic spine dumbbell neurogenic tumor: a case report and literature review.

Authors:  Siwei Bi; Jun Gu; Chenggong Hu
Journal:  BMC Surg       Date:  2020-09-21       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.